Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1982 Jul;76(3):447–452. doi: 10.1111/j.1476-5381.1982.tb09238.x

Drugs that increase gamma-aminobutyric acid transmission protect against the high pressure neurological syndrome.

A R Bichard, H J Little
PMCID: PMC2071799  PMID: 6286024

Abstract

1 The effects on the high pressure neurological syndrome (HPNS) of drugs which facilitate gamma-aminobutyric acid (GABA) transmission were investigated. Threshold pressures for the onset of the behavioural signs of the HPNS in mice--tremors and convulsions were established. 2 Flurazepam hydrochloride 20 and 10 mg/kg and sodium valproate 800 and 400 mg/kg substantially raised the threshold pressures for both tremor and convulsions. 3 Amino-oxyacetic acid 35 and 25 mg/kg and diaminobutyric acid 600 mg/kg also significantly increased the thresholds. Muscimol 1 mg/kg (and 150 ng i.c.v.) was ineffective at non-toxic doses. 4 These effects paralleled the drugs' ability to raise the convulsion threshold to intravenous infusion of bicuculline in mice. 5 These results demonstrate that drugs with actions more selective than those of the general anaesthetics are effective against the HPNS. It is also possible that there is a GABAergic component to the effects of general anaesthetics on the HPNS.

Full text

PDF
447

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beaver R. W., Brauer R. W., Lahser S. Interaction of central nervous system effects of high pressures with barbiturates. J Appl Physiol Respir Environ Exerc Physiol. 1977 Aug;43(2):221–229. doi: 10.1152/jappl.1977.43.2.221. [DOI] [PubMed] [Google Scholar]
  2. Brauer R. W., Beaver R. W., Lahser S., McCall R. D., Venters R. Comparative physiology of the high-pressure neurological syndrome--compression rate effects. J Appl Physiol Respir Environ Exerc Physiol. 1979 Jan;46(1):128–135. doi: 10.1152/jappl.1979.46.1.128. [DOI] [PubMed] [Google Scholar]
  3. Green C. J., Halsey M. J., Wardley-Smith B. Possible protection against some of the physiological effects of high pressure [proceedings]. J Physiol. 1977 May;267(1):46P–47P. [PubMed] [Google Scholar]
  4. Huang L. Y., Barker J. L. Pentobarbital: stereospecific actions of (+) and (-) isomers revealed on cultured mammalian neurons. Science. 1980 Jan 11;207(4427):195–197. doi: 10.1126/science.7350656. [DOI] [PubMed] [Google Scholar]
  5. Kaufmann P. G., Bennett P. B., Farmer J. C., Jr Cerebellar and cerebral electroencephalogram during the high pressure nervous syndrome (HPNS) in rats. Undersea Biomed Res. 1977 Dec;4(4):391–402. [PubMed] [Google Scholar]
  6. Kerwin R. W., Olpe H. R., Schmutz M. The effect of sodium-n-dipropyl acetate on gamma-aminobutyric acid-dependent inhibition in the rat cortex and substantia nigra in relation to its anticonvulsant activity. Br J Pharmacol. 1980;71(2):545–551. doi: 10.1111/j.1476-5381.1980.tb10971.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Koblin D. D., Little H. J., Green A. R., Daniels S., Smith E. B., Paton W. D. Brain monoamines and the high pressure neurological syndrome. Neuropharmacology. 1980 Nov;19(11):1031–1038. doi: 10.1016/0028-3908(80)90098-2. [DOI] [PubMed] [Google Scholar]
  8. Lever M. J., Miller K. W., Paton W. D., Smith E. B. Pressure reversal of anaesthesia. Nature. 1971 Jun 11;231(5302):368–371. doi: 10.1038/231368a0. [DOI] [PubMed] [Google Scholar]
  9. Menon M. K., Vivonia C. A. Muscimol-induced myoclonic jerks in mice. Neuropharmacology. 1981 May;20(5):441–444. doi: 10.1016/0028-3908(81)90174-x. [DOI] [PubMed] [Google Scholar]
  10. Menon M. K., Vivonia C. A. Serotonergic drugs, benzodiazepines and baclofen block muscimol-induced myoclonic jerks in a strain of mice. Eur J Pharmacol. 1981 Jul 17;73(2-3):155–161. doi: 10.1016/0014-2999(81)90087-x. [DOI] [PubMed] [Google Scholar]
  11. Nicoll R. A. The effects of anaesthetics on synaptic excitation and inhibition in the olfactory bulb. J Physiol. 1972 Jun;223(3):803–814. doi: 10.1113/jphysiol.1972.sp009875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Nutt D. J., Cowen P. J., Green A. R. On the measurement in rats of the convulsant effect of drugs and the changes which follow electroconvulsive shock. Neuropharmacology. 1980 Oct;19(10):1017–1023. doi: 10.1016/0028-3908(80)90014-3. [DOI] [PubMed] [Google Scholar]
  13. Paton W. D. Experiments on the convulsant and anaesthetic effects of oxygen. Br J Pharmacol Chemother. 1967 Mar;29(3):350–366. doi: 10.1111/j.1476-5381.1967.tb01967.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Pedley T. A., Horton R. W., Meldrum B. S. Electroencephalographic and behavioral effects of a GABA agonist (muscimol) on photosensitive epilepsy in the baboon, papio papio. Epilepsia. 1979 Aug;20(4):409–416. doi: 10.1111/j.1528-1157.1979.tb04821.x. [DOI] [PubMed] [Google Scholar]
  15. Ritter T., Vandrovec R., Wilson R. H. Gamma aminobutyric acid levels in brains of mice exposed to 20, 40, and 60 atmospheres He-O2 for 24 hours. Aerosp Med. 1969 Sep;40(9):994–997. [PubMed] [Google Scholar]
  16. Wood J. D., Peesker S. J. The anticonvulsant action of GABA-elevating agents: a re-evaluation. J Neurochem. 1975 Sep;25(3):277–282. doi: 10.1111/j.1471-4159.1975.tb06966.x. [DOI] [PubMed] [Google Scholar]
  17. Wood J. D., Watson W. J., Ducker A. J. Oxygen poisoning in various mammalian species and the possible role of gamma-aminobutyric acid metabolism. J Neurochem. 1967 Nov;14(11):1067–1074. doi: 10.1111/j.1471-4159.1967.tb09517.x. [DOI] [PubMed] [Google Scholar]
  18. Wood J. D., Watson W. J. The effect of amino-oxyacetic acid and hydroxylamine on rats breathing oxygen at high pressure. J Neurochem. 1965 Jul;12(7):663–669. doi: 10.1111/j.1471-4159.1965.tb04260.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES